Cisplatin

Advancements in the treatment of biliary tract cancers

Management of biliary tract cancers with targeted therapies

Gemcitabine, cisplatin, and nab-paclitaxel in advanced biliary tract cancers

Takeaways in hepatocellular carcinoma at ASCO GI 2023

Biomarker analysis of nivolumab in patients with advanced refractory biliary tract cancer

The role of immunotherapy in cholangiocarcinoma

SWOG 1815: gemcitabine, cisplatin, and nab-paclitaxel in biliary tract cancer

Overcoming resistance to ICIs in biliary tract cancers

EXTREME regimen vs. cetuximab + cisplatin + paclitaxel for recurrent/metastatic head and neck cancer

Unmet needs in pediatric hepatoblastoma management

EV-103 Cohort K: enfortumab vedotin +/- pembro in untreated cis-ineligible patients with mUC

CheckMate 648: Novel treatment for patients with advanced esophageal squamous cell carcinoma

Phase II study of neoadjuvant atezolizumab with gemcitabine and cisplatin in patients with MIBC

Head and neck cancer at ASCO 2022

Replacing the current standard of care for urothelial carcinoma

Primary analysis of SAKK 06/17: perioperative chemoimmunotherapy with durvalumab for operable MIUC